| REVIEW ARTICLE |
|
| Year : 2019 | Volume
: 52
| Issue : 5 | Page : 155-160 |
|
|
Blue-light cystoscopy and narrow-band imaging in bladder cancer management
Zhijiang Zang, Qinghui Wu, Edmund Chiong
Department of Urology, National University Health System, Singapore 119228, Singapore
Correspondence Address:
Prof. Edmund Chiong
Department of Urology, National University Health System, NUHS Tower Block, Level 8, 1E Kent Ridge Road, Singapore 119228
Singapore
 Source of Support: None, Conflict of Interest: None  | 2 |
DOI: 10.4103/fjs.fjs_133_18
|
|
|
Despite the high resolution of modern imaging technology including computed tomography and magnetic resonance imaging, cystoscopy remains the gold standard method for detecting bladder cancer. Cystoscopy is conventionally conducted with white light visualization, and the pitfalls of white light cystoscopy are well-recognized. Novel technologies to enhance visualization of bladder lesion have emerged during the past 20 years. Among them, blue-light cystoscopy (BLC) and narrow-band imaging (NBI) are the most promising and well-studied. Many clinical trials have suggested the benefit of these two technologies. In this review, we aim to summarize the data, evidence, and current role of BLC and NBI in clinical practice.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
